Literature DB >> 6118694

How well do low levels of rubella antibody protect?

S O'Shea, G Parsons, J M Best, J E Banatvala, H H Balfour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6118694     DOI： 10.1016/s0140-6736(81)91517-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Multicenter evaluation of a novel quantification method for rubella and toxoplasmosis antibodies.

Authors:  B Martens-Düring; H D Dopatka
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

2.  Rubella vaccination: remaining problems.

Authors:  J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01

Review 3.  Rubella vaccination.

Authors:  J Forster
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

4.  Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals.

Authors:  L A Mitchell; M K Ho; J E Rogers; A J Tingle; R G Marusyk; J M Weber; P Duclos; M L Tepper; M Lacroix; M Zrein
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella.

Authors:  P Arneborn; G Biberfeld
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Immune responses to wild and vaccine rubella viruses after rubella vaccination.

Authors:  M G Cusi; R Metelli; P E Valensin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  A bio-engineered rubella E1 antigen.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  Rubella vaccination: persistence of antibodies for up to 16 years.

Authors:  S O'Shea; J M Best; J E Banatvala; W C Marshall; J A Dudgeon
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.